CV Therapeutics starts Phase II CHF trial

CVTX began a U.S. placebo-controlled Phase II

Read the full 73 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE